Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.17 by 64.71 percent. This is a 70 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $853.000 million which missed the analyst consensus estimate of $925.530 million by 7.84 percent. This is a 14.44 percent decrease over sales of $997.000 million the same period last year.